Literature DB >> 28084859

Radiotherapy-induced vaginal fibrosis in cervical cancer survivors.

Alexandra Hofsjö1, Nina Bohm-Starke2,3, Bo Blomgren2,4, Helen Jahren5, Gunnar Steineck6,7, Karin Bergmark7,8.   

Abstract

BACKGROUND: Cervical cancer survivors treated with radiotherapy report vaginal inelasticity and decreased lubrication that may affect their sexual health, but it is unknown which normal tissue reactions mediate these symptoms. The aim of this study was to investigate the morphology of the connective tissue of the vaginal wall in cervical cancer survivors treated with radiotherapy.
MATERIAL AND METHODS: We recruited 34 cervical cancer survivors treated with radiotherapy and 37 age-matched controls. Via clinical examination the degree of vaginal atrophy and pelvic fibrosis were estimated. We collected vaginal biopsies, which underwent morphometric analysis focused on elastin and collagen. Additionally, radiation dose at biopsy site were calculated and correlated to the clinical and morphological findings.
RESULTS: The survivors had marked morphological vaginal changes, most prominent in the survivors that had received the highest radiation dose at the biopsy site. Mucosal atrophy was observed in 91% and pelvic fibrosis in 97%. A shorter vagina was measured; 7.0 cm versus 10.3 cm in controls (p < 0.001). The area fraction of elastin was greater in survivors; 10.0% (range 5.8-12.9), compared with controls; 3.4% (range 1.8-5.8), p < 0.001. The survivors had signs of elastosis with thick aggregated elastin fibers irregularly scattered throughout the connective tissue, while the controls had elastin fibers in a thin sub-epithelial layer. The area fraction of high density collagen in the connective tissue was larger among the survivors (p < 0.001). The collagen with the highest density (fibrosis) was more common in the group of cancer survivors that had received external radiation.
CONCLUSIONS: We found drastic differences in the vaginal wall between the irradiated cervical cancer survivors and the controls, indicating that radiotherapy-induced vaginal symptoms are mediated by connective tissue fibrosis and elastosis. Our results also support that patients treated with external radiation have the highest risk of developing vaginal fibrosis with impairment of their sexual health.

Entities:  

Mesh:

Year:  2017        PMID: 28084859     DOI: 10.1080/0284186X.2016.1275778

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  8 in total

1.  A single-arm clinical trial investigating the effectiveness of a non-hormonal, hyaluronic acid-based vaginal moisturizer in endometrial cancer survivors.

Authors:  Jeanne Carter; Shari Goldfarb; Raymond E Baser; Deborah J Goldfrank; Barbara Seidel; Lisania Milli; Sally Saban; Cara Stabile; Jocelyn Canty; Ginger J Gardner; Elizabeth L Jewell; Yukio Sonoda; Marisa A Kollmeier; Kaled M Alektiar
Journal:  Gynecol Oncol       Date:  2020-06-08       Impact factor: 5.482

2.  Extended duration of dilator use beyond 1 year may reduce vaginal stenosis after intravaginal high-dose-rate brachytherapy.

Authors:  John M Stahl; Jack M Qian; Christopher J Tien; David J Carlson; Zhe Chen; Elena S Ratner; Henry S Park; Shari Damast
Journal:  Support Care Cancer       Date:  2018-09-05       Impact factor: 3.603

3.  Angiogenic CD34+CD146+ adipose-derived stromal cells augment recovery of soft tissue after radiotherapy.

Authors:  Nestor M Diaz Deleon; Sandeep Adem; Christopher V Lavin; Darren B Abbas; Michelle Griffin; Megan E King; Mimi R Borrelli; Ronak A Patel; Evan J Fahy; Daniel Lee; Abra H Shen; Arash Momeni; Michael T Longaker; Derrick C Wan
Journal:  J Tissue Eng Regen Med       Date:  2021-10-05       Impact factor: 3.963

4.  Radiation induces changes in toll-like receptors of the uterine cervix of the rat.

Authors:  Marie Francoise Mukanyangezi; Lucie Podmolíková; Wurood Al Hydad; Gunnar Tobin; Daniel Giglio
Journal:  PLoS One       Date:  2019-04-18       Impact factor: 3.240

5.  Clinical and Psychological Outcomes of the Use of Vaginal Dilators After Gynaecological Brachytherapy: a Randomized Clinical Trial.

Authors:  Taís Marques Cerentini; Júlia Schlöttgen; Patrícia Viana da Rosa; Valentina Lucia La Rosa; Salvatore Giovanni Vitale; Pierluigi Giampaolino; Gaetano Valenti; Stefano Cianci; Fabrício Edler Macagnan
Journal:  Adv Ther       Date:  2019-06-17       Impact factor: 3.845

Review 6.  Interventions Preventing Vaginitis, Vaginal Atrophy after Brachytherapy or Radiotherapy Due to Malignant Tumors of the Female Reproductive Organs-A Systematic Review.

Authors:  Adrianna Wierzbicka; Dorota Mańkowska-Wierzbicka; Stanisław Cieślewicz; Marta Stelmach-Mardas; Marcin Mardas
Journal:  Int J Environ Res Public Health       Date:  2021-04-08       Impact factor: 3.390

7.  Comparison of vaginal microbiota in gynecologic cancer patients pre- and post-radiation therapy and healthy women.

Authors:  Despina Tsementzi; Angela Pena-Gonzalez; Jinbing Bai; Yi-Juan Hu; Pretesh Patel; Joseph Shelton; Mary Dolan; Jessica Arluck; Namita Khanna; Lesley Conrad; Isabelle Scott; Tony Y Eng; Konstantinos T Konstantinidis; Deborah W Bruner
Journal:  Cancer Med       Date:  2020-04-01       Impact factor: 4.452

8.  Cohort profile: an observational longitudinal data collection of health aspects in a cohort of female cancer survivors with a history of pelvic radiotherapy-a population-based cohort in the western region of Sweden.

Authors:  Linda Åkeflo; Gail Dunberger; Eva Elmerstig; Viktor Skokic; Gunnar Steineck; Karin Bergmark
Journal:  BMJ Open       Date:  2021-07-21       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.